Sunil Healthcare Ltd Stock Price Today (NSE: SUNLOC)
Fundamental Score
Sunil Healthcare Ltd Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Sunil Healthcare Ltd share price today is ₹70.00, up +1.42% on NSE/BSE as of 7 August 2026. Sunil Healthcare Ltd (SUNLOC) is a Small-cap company in the Pharmaceuticals sector with a market capitalisation of ₹69.75 (Cr). The 52-week high for SUNLOC share price is ₹88.70 and the 52-week low is ₹56.35. At a P/E ratio of 16.97x, SUNLOC is currently trading below its industry average P/E of 34.89x. The company has a Return on Equity (ROE) of 6.01% and a debt-to-equity ratio of 0.80.
Sunil Healthcare Ltd Share Price Chart — NSE/BSE Historical Performance
Sunil Healthcare Ltd share price chart: -4.78% return over the past month. 52-week high ₹88.70, 52-week low ₹56.35.
Sunil Healthcare Ltd — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹69.00 | ₹70.00 | ₹68.00 | ₹69.02 | 165.00 (Cr) | |
| ₹69.16 | ₹72.48 | ₹67.00 | ₹72.39 | 786.00 (Cr) | |
| ₹66.50 | ₹70.94 | ₹66.50 | ₹68.00 | 365.00 (Cr) | |
| ₹67.55 | ₹72.50 | ₹67.55 | ₹72.39 | 1.58K (Cr) | |
| ₹73.90 | ₹73.90 | ₹67.50 | ₹67.55 | 281.00 (Cr) | |
| ₹73.90 | ₹73.90 | ₹71.48 | ₹71.90 | 17.00 (Cr) | |
| ₹72.50 | ₹72.50 | ₹71.45 | ₹71.45 | 4.00 (Cr) | |
| ₹72.50 | ₹72.50 | ₹71.99 | ₹72.50 | 6.00 (Cr) | |
| ₹66.80 | ₹70.00 | ₹66.40 | ₹68.50 | 10.00 (Cr) | |
| ₹72.17 | ₹72.17 | ₹69.30 | ₹70.99 | 110.00 (Cr) |
Sunil Healthcare Ltd — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹67.55 | ₹72.50 | ₹66.50 | ₹69.02 | +2.18% | |
| ₹70.00 | ₹74.00 | ₹66.40 | ₹67.55 | -3.50% | |
| ₹63.50 | ₹72.35 | ₹60.20 | ₹67.27 | +5.94% | |
| ₹65.48 | ₹67.90 | ₹60.00 | ₹63.50 | -3.02% | |
| ₹63.90 | ₹67.50 | ₹56.35 | ₹64.20 | +0.47% | |
| ₹69.50 | ₹70.00 | ₹58.40 | ₹61.97 | -10.83% | |
| ₹70.00 | ₹73.00 | ₹62.30 | ₹66.00 | -5.71% | |
| ₹70.11 | ₹76.90 | ₹62.00 | ₹65.00 | -7.29% | |
| ₹72.50 | ₹72.60 | ₹62.70 | ₹72.55 | +0.07% | |
| ₹72.00 | ₹80.00 | ₹66.55 | ₹72.50 | +0.69% | |
| ₹79.38 | ₹82.50 | ₹70.00 | ₹72.00 | -9.30% | |
| ₹79.90 | ₹88.70 | ₹73.26 | ₹79.38 | -0.65% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Sunil Healthcare Ltd Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Sunil Healthcare Ltd Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SUNLOC across key market metrics for learning purposes.
Positive Indicators
6 factors identified
Attractive Valuation (P/E: 16.97 vs Industry: 34.89)
Observation: Trading at discount to industry peers.
Analysis: P/E below industry average may present value opportunity.
Robust Profit Growth (355.56%)
Observation: Strong year-over-year profit expansion demonstrates business momentum.
Analysis: Profit growth >20% indicates effective execution and market opportunity capture.
Excellent EPS Growth (54.66% CAGR)
Observation: Outstanding 5-year earnings per share compound growth.
Analysis: EPS CAGR >15% indicates strong wealth creation potential.
Strong Profit Growth Track Record (54.66% CAGR)
Observation: Consistent 5-year profit compound annual growth rate.
Analysis: Profit CAGR >15% demonstrates scalable business model.
Balanced Promoter Holding (73.53%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
7 factors identified
Below-Average Return on Equity (6.01%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.52%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Revenue Contraction (-6.98%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Limited Growth History (-0.65% CAGR)
Observation: Below-average 5-year sales growth trajectory.
Analysis: Low sales CAGR may indicate mature markets or limited growth opportunities.
Weak Interest Coverage (1.38x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
Limited Institutional Interest (FII+DII: 0.10%)
Observation: Low institutional participation may affect liquidity.
Analysis: Limited institutional interest may indicate size constraints or visibility issues.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Sunil Healthcare Ltd vs Pharmaceuticals Peers
Peer Comparison - Pharmaceuticals
Compare Sunil Healthcare Ltd with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
Sunil Healthcare LtdSunil Healthcar...Selected✓ SUNLOC • 537253 | 48.8/100 | ₹70.00₹70 | ₹69.75₹69.75 | 16.97Average 17.0 Average | 6.01%Poor 6.01% Poor | 6.52%Poor 6.52% Poor | 0.80Good 0.8 Good | 54.66%Excellent 54.66% Excellent | -0.65%Poor -0.65% Poor | 0.00% |
Sun Pharmaceutical Industries LtdSun Pharmaceuti... SUNPHARMA • 524715 | 66.4/100 | ₹1990.50₹1991 | ₹468821.49₹468821.49 | 37.73Average 37.7 Average | 15.95%Good 15.95% Good | 20.53%Excellent 20.53% Excellent | 0.06Excellent 0.1 Excellent | 16.75%Excellent 16.75% Excellent | 11.78%Good 11.78% Good | 0.82% |
Divis Laboratories LtdDivis Laborator... DIVISLAB • 532488 | 56.3/100 | ₹8056.00₹8056 | ₹193163.97₹193163.97 | 73.64Average 73.6 Average | 16.53%Good 16.53% Good | 21.96%Excellent 21.96% Excellent | 0.00Excellent 0.0 Excellent | 5.71%Good 5.71% Good | 8.67%Good 8.67% Good | 0.41% |
Torrent Pharmaceuticals LtdTorrent Pharmac... TORNTPHARM • 500420 | 51.4/100 | ₹5122.80₹5123 | ₹169902.02₹169902.02 | 77.52Average 77.5 Average | 27.43%Excellent 27.43% Excellent | 15.19%Good 15.19% Good | 1.79Average 1.8 Average | 12.07%Good 12.07% Good | 11.80%Good 11.80% Good | 0.76% |
Cipla LtdCipla Ltd... CIPLA • 500087 | 40.2/100 | ₹1473.20₹1473 | ₹116131.81₹116131.81 | 30.51Average 30.5 Average | 11.60%Average 11.60% Average | 15.49%Good 15.49% Good | 0.02Excellent 0.0 Excellent | 9.94%Good 9.94% Good | 8.01%Good 8.01% Good | 0.90% |
Zydus Lifesciences LtdZydus Lifescien... ZYDUSLIFE • 532321 | 74.1/100 | ₹1078.30₹1078 | ₹115375.77₹115375.77 | 21.26Average 21.3 Average | 21.25%Excellent 21.25% Excellent | 21.14%Excellent 21.14% Excellent | 0.46Excellent 0.5 Excellent | 18.77%Excellent 18.77% Excellent | 12.45%Good 12.45% Good | 0.09% |
Lupin LtdLupin Ltd... LUPIN • 500257 | 83.4/100 | ₹2415.00₹2415 | ₹113976.53₹113976.53 | 20.04Average 20.0 Average | 28.68%Excellent 28.68% Excellent | 29.93%Excellent 29.93% Excellent | 0.29Excellent 0.3 Excellent | 37.02%Excellent 37.02% Excellent | 13.02%Good 13.02% Good | 0.72% |
Mankind Pharma LtdMankind Pharma ... MANKIND • 543904 | 61.5/100 | ₹2469.60₹2470 | ₹105053.91₹105053.91 | 52.29Average 52.3 Average | 13.12%Average 13.12% Average | 13.50%Average 13.50% Average | 0.39Excellent 0.4 Excellent | 10.52%Good 10.52% Good | 18.10%Excellent 18.10% Excellent | 0.04% |
Dr Reddys Laboratories LtdDr Reddys Labor... DRREDDY • 500124 | 41/100 | ₹1148.10₹1148 | ₹102660.46₹102660.46 | 25.62Average 25.6 Average | 11.22%Average 11.22% Average | 13.04%Average 13.04% Average | 0.20Excellent 0.2 Excellent | 15.44%Excellent 15.44% Excellent | 12.09%Good 12.09% Good | 0.65% |
Aurobindo Pharma LtdAurobindo Pharm... AUROPHARMA • 524804 | 24.6/100 | ₹1580.20₹1580 | ₹90035.87₹90035.87 | 25.38Average 25.4 Average | 10.06%Average 10.06% Average | 12.80%Average 12.80% Average | 0.21Excellent 0.2 Excellent | 0.80%Average 0.80% Average | 6.32%Good 6.32% Good | 0.26% |
Laurus Labs LtdLaurus Labs Ltd... LAURUSLABS • 540222 | 34.1/100 | ₹1816.20₹1816 | ₹84016.75₹84016.75 | 93.94Average 93.9 Average | 18.30%Good 18.30% Good | 17.76%Good 17.76% Good | 0.48Excellent 0.5 Excellent | -1.89%Poor -1.89% Poor | 7.19%Good 7.19% Good | 0.13% |
Top Pharmaceuticals Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Sun Pharmaceutical Industries Ltd share price468821.49 Cr
- Divis Laboratories Ltd share price193163.97 Cr
- Torrent Pharmaceuticals Ltd share price169902.02 Cr
- Cipla Ltd share price116131.81 Cr
- Zydus Lifesciences Ltd share price115375.77 Cr
Sunil Healthcare Ltd Quarterly Performance
Latest quarterly metrics for SUNLOC — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-6.98%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
355.56%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
-0.65%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
54.66%
Compounded annual net profit growth over 5 years
Sunil Healthcare Ltd Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SUNLOC — calculated from daily price history
Momentum is balanced — neither overbought nor oversold.
Technical indicators are for educational purposes only. Not investment advice.
Sunil Healthcare Ltd Financial Statements
Annual income statement, balance sheet and cash flow for Sunil Healthcare Ltd (SUNLOC) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Sunil Healthcare Ltd
About SUNLOC (Sunil Healthcare Ltd)
Sunil Healthcare Ltd. is a prominent manufacturer specializing in innovative capsule solutions for the pharmaceutical and nutraceutical industries, both within India and across int...ernational markets. They've carved a niche for themselves by focusing on the production of empty hard capsules, encompassing a wide range of materials to meet diverse customer needs. Their commitment to quality and adaptability is evident in their broad product portfolio. The company's expertise extends beyond standard gelatin capsules, embracing modern advancements in material science. Sunil Healthcare manufactures capsules from Hydroxypropyl Methylcellulose (HPMC), catering to the growing demand for vegetarian and vegan options. Furthermore, they produce pullulan capsules derived from tapioca, offering a naturally sourced alternative. This diversification allows them to serve a broader spectrum of pharmaceutical and health-conscious consumers. Beyond capsules, Sunil Healthcare ventures into the realm of traditional medicine, offering a range of Ayurvedic products based on time-tested herbs and formulations. They utilize ingredients such as turmeric, ginger, and ashwagandha. This complementary business demonstrates Sunil Healthcare's dedication to holistic wellness, blending modern pharmaceutical technology with ancient healing practices, reinforcing its commitment to health solutions.
Company Details
Key Leadership
SUNLOC Share Price: Frequently Asked Questions
What is the current share price of Sunil Healthcare Ltd?
Sunil Healthcare Ltd (SUNLOC) trades at ₹70.00 on NSE and BSE. Market cap ₹69.75 (Cr). Educational data only.
What is the P/E ratio of Sunil Healthcare Ltd?
Sunil Healthcare Ltd has a P/E of 16.97x vs industry average 34.89x.
What is the Bull Run score for Sunil Healthcare Ltd?
Sunil Healthcare Ltd has a Bull Run score of 48.8/100 based on 25+ financial parameters.
Does Sunil Healthcare Ltd pay dividends?
Sunil Healthcare Ltd has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Sunil Healthcare Ltd?
Sunil Healthcare Ltd has ROE of 6.01%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Sunil Healthcare Ltd?
Sunil Healthcare Ltd has debt-to-equity of 0.80.
Is Sunil Healthcare Ltd a good investment?
Bull Run gives Sunil Healthcare Ltd a score of 48.8/100. This is not investment advice — consult a SEBI-registered advisor.